Elicio Therapeutics (ELTX) PT Raised to $17.50 at Rodman & Renshaw
Tweet Send to a Friend
Rodman & Renshaw analyst Michael King Jr. raised the price target on Elicio Therapeutics (NASDAQ: ELTX) to $17.50 (from $17.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
